# RESPOND TO PREVENT: Stepwise Pharmacy Naloxone Study

> **NCT03545321** · NA · UNKNOWN · sponsor: **Brandeis University** · enrollment: 450 (estimated)

## Conditions studied

- Pharmacies
- Opioid Use
- Patient Safety

## Interventions

- **BEHAVIORAL:** MOON+

## Key facts

- **NCT ID:** NCT03545321
- **Lead sponsor:** Brandeis University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-09
- **Primary completion:** 2022-11
- **Final completion:** 2022-11
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2022-03-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03545321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03545321, "RESPOND TO PREVENT: Stepwise Pharmacy Naloxone Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03545321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*